AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

3D Printers for Autonomy in the Care of Inpatients in Continuing and Rehabilitation Care

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Intercommunal de Toulon La Sey…
💬

In plain words

What the trial is, and whether it could suit you

Patients hospitalized in Continuing and Rehabilitation Care Units (CRCU) are for the most part elderly people suffering from neurodegenerative diseases, requiring individual, personalized rehabilitation care. Some of these patients require ergotherapy to help them regain functional ability in everyday activities. The ergotherapist organizes therapeutic activities tailored to patients' needs, with a view to optimizing their level of autonomy. Loss of autonomy is closely linked to nutritional status, which often tends towards malnutrition in patients admitted to CRCU, with deleterious consequences for the elderly. The use of technical aids to facilitate meal-taking could be a way of alleviating undernutrition. A technical aid is defined as a material aid that enables elderly or disabled people to compensate for a limitation in activity. The investigators are interested in the use of ada

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patient hospitalized in a Continuing Care and Rehabilitation department ; 2. Patient suffering from a neurodegenerative disease (Mini Mental Test score \> 15); 3. Age ≥ 18 years; 4. Patient with a score ≥ 3 on the "Eating" criterion of the Katz scale (corresponding to the need for at least partial assistance with meals). Exclusion Criteria: 1. Opposition of the patient or his relatives to participating in the research ; 2. Patient unable to use hands to eat (amputation, paralysis, etc.); 3. Patient under court protection; 4. Pregnant, parturient or breast-feeding woman; 5. Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the study objectives.
💊

What it tests

  • adapted cutlery handle printed with 3D printer
📍

Where

2 sites
SSR Pierre Chevalier
Hyères, France
Hôpital Georges Clemenceau
La Garde, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy